Interim guidance for use of 23-valent pneumococcal polysaccharide vaccine during novel influenza A (H1N1) outbreak

http://www.cdc.gov/h1n1flu/guidance/ppsv_h1n1.htm

Guidelines on the 23-valent pneumococcal polysaccharide vaccine (PPSV23) use to prevent pneumococcal infections during the outbreak of novel influenza A(H1N1).

Originator(s): United States. Department of Health and Human Services - HHS. Centers for Disease Control and Prevention - CDC
Resource added in: 08/07/2009
Available languages: English
Influenza, Human/complications, Pneumococcal Infections/prevention & control, Risk Groups, Influenza A Virus, H1N1 Subtype, eic useic useic useic useic useic use, Gripe suína, Influenza suína, Gripe porcina, Influenza porcina, Swine influenza, Swine flu
  • Share
  • Suggest tag
    [X]
    Suggestions
    Separated by comma
    [X]
    Thank you for your suggestion.
    Communication problem. Please try again later.
  • Report error
    [X]
    Reason
    New Link (Optional)
    [X]
    Thank you for your report.
    Communication problem. Please try again later.
comments powered by Disqus

More related